Optimal long-term humoral responses to replication-defective herpes simplex virus require CD21/CD35 complement receptor expression on stromal cells

被引:22
作者
Brockman, Mark A.
Verschoor, Admar
Zhu, Jia
Carroll, Michael C.
Knipe, David M.
机构
[1] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Pediat & Pathol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Program Virol, Boston, MA 02115 USA
[4] CBR Inst Biomed Res, Boston, MA 02115 USA
关键词
FOLLICULAR DENDRITIC CELLS; LIVED PLASMA-CELLS; IMMUNE-RESPONSES; VIRAL-INFECTION; IMMUNIZATION; ANTIGEN; MUTANT; PROTECTION; INDUCTION; ANTIBODY;
D O I
10.1128/JVI.01421-05
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Replication-defective herpes simplex virus (HSV) strains elicit durable immune responses and protect against virulent HSV challenge in mice, despite being unable to establish latent infection in neuronal cells. Mechanisms for generating long-lived immunity in the absence of viral persistence remain uncertain. In animals immunized with replication-defective HSV, durable serum immunoglobulin G (IgG) responses were elicited. Surprisingly, Western blot analyses revealed that the specificities of antiviral IgG changed over time, and antibody reactivity to some viral proteins was detected only very late. Thus, some of the durable IgG activity appeared to be contributed by either new or significantly enhanced antibody responses at late times. Following immunization, radiation bone marrow-chimeric mice lacking complement receptors CD21 and CD35 on stromal cells elicited only short-lived serum IgG and failed to mount recall responses to subsequent HSV exposure. Our results suggest that complement-mediated retention of viral antigens by stromal cells, such as follicular dendritic cells, is critical for optimal maintenance of antibody responses and B-cell memory following vaccination with replication-defective HSV.
引用
收藏
页码:7111 / 7117
页数:7
相关论文
共 40 条
[1]   Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen [J].
Ahearn, JM ;
Fischer, MB ;
Croix, D ;
Goerg, S ;
Ma, MH ;
Xia, JR ;
Zhou, XN ;
Howard, RG ;
Rothstein, TL ;
Carroll, MC .
IMMUNITY, 1996, 4 (03) :251-262
[2]   REGULATION OF IGG ANTIBODY-TITERS BY THE AMOUNT OF PERSISTING IMMUNE-COMPLEXED ANTIGEN [J].
BACHMANN, MF ;
KUNDIG, TM ;
HENGARTNER, H ;
ZINKERNAGEL, RM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) :2567-2570
[3]   Induction of long-lived germinal centers associated with persisting antigen after viral infection [J].
Bachmann, MF ;
Odermatt, B ;
Hengartner, H ;
Zinkernagel, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :2259-2269
[4]   B lymphocyte memory:: Role of stromal cell complement and FcγRIIB receptors [J].
Barrington, RA ;
Pozdnyakova, O ;
Zafari, MR ;
Benjamin, CD ;
Carroll, MC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (09) :1189-1199
[5]   A Genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease [J].
Boursnell, MEG ;
Entwisle, C ;
Blakeley, D ;
Roberts, C ;
Duncan, IA ;
Chisholm, SE ;
Martin, GM ;
Jennings, R ;
Challanain, DN ;
Sobek, I ;
Inglis, SC ;
McLean, CS .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (01) :16-25
[6]   Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8(+) cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1 [J].
Brehm, MA ;
Bonneau, RH ;
Knipe, DM ;
Tevethia, SS .
JOURNAL OF VIROLOGY, 1997, 71 (05) :3534-3544
[7]   Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity [J].
Brockman, MA ;
Knipe, DM .
JOURNAL OF VIROLOGY, 2002, 76 (08) :3678-3687
[8]   Humoral immune responses in Cr2-/- mice:: Enhanced affinity maturation but impaired antibody persistence [J].
Chen, ZB ;
Koralov, SB ;
Gendelman, M ;
Carroll, MC ;
Kelsoe, G .
JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4522-4532
[9]   Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2 [J].
Da Costa, X ;
Kramer, MF ;
Zhu, J ;
Brockman, MA ;
Knipe, DM .
JOURNAL OF VIROLOGY, 2000, 74 (17) :7963-7971
[10]   Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection [J].
Da Costa, XJ ;
Jones, CA ;
Knipe, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6994-6998